Healthcare Regulation (HIPAA)

In an era of rampant data breaches, the in-home care provider's new 'gold standard' certification raises the bar for protecting sensitive patient data.

A new study reveals a sharp drop in prescription fills at just $35, highlighting a critical affordability crisis that even insured patients can't escape.

A new partnership embeds specialty drug ordering into clinic software, promising to boost efficiency and patient care in the booming infusion market.

As compliance demands intensify, Charles IT hires Jessica Golle as CRO to scale its services for regulated industries across the Northeast and Mid-Atlantic.

New research on the gut-brain axis and smarter antibiotic use is transforming veterinary medicine, moving from theory to practice for healthier pets.

A new partnership between Algorized and AKM promises to monitor human vitals and safety without cameras, ushering in an era of awareness over surveillance.

Europe's top cancer center adopts an AI orchestration platform, aiming to cut wait times, boost efficiency, and reshape the patient journey.

SERB Pharma's acquisition of Idefirix® rights offers new hope to thousands of highly sensitized patients previously unable to receive a kidney transplant.

A Minnesota jury found major companies liable for a man's terminal cancer from asbestos in talc powders, highlighting a growing legal battle.

Mineralys Therapeutics' lorundrostat shows promise for millions with uncontrolled blood pressure and kidney disease, targeting a key hormonal driver.

With a new CEO who led a startup to FDA approval and acquisition, VahatiCor aims to commercialize its novel A-FLUX system for millions with chronic chest pain.

A new $17.9M government contract will fund an AI to analyze phone data, aiming to revolutionize how we detect and treat behavioral health issues.

Beyond just tracking data, SIBIONICS's new AI tools aim to tell diabetes patients what to do next, heralding a new era of personalized care.

A new tool from a national lab uses de-identified test data to give health officials an early warning on emerging disease threats like pertussis and flu.

ODAIA's new AI platform moves beyond static segments to treat each doctor as a 'segment of one,' promising to boost engagement and slash marketing waste.

Former Trade Desk CMO Ian Colley joins DeepIntent, signaling an aggressive push into AI-powered marketing for the specialized healthcare advertising sector.

A new partnership aims to tackle AI's biggest security risks, signaling a major industry shift from functional AI to production-ready, secure AI.

A new company emerges from Purdue Pharma's bankruptcy, owned by a non-profit and tasked with fighting the very opioid crisis its predecessor fueled.

A new survey reveals a massive gap between security goals and reality, as nearly all firms want microsegmentation but few successfully deploy it.

H1 launched its Site Network Suite, an AI platform promising to slash clinical trial feasibility times and reshape how sponsors and research sites connect.